RU93030389A - MEANS RESTORING THE FUNCTION OF THE MESH EYE - Google Patents
MEANS RESTORING THE FUNCTION OF THE MESH EYEInfo
- Publication number
- RU93030389A RU93030389A RU93030389/14A RU93030389A RU93030389A RU 93030389 A RU93030389 A RU 93030389A RU 93030389/14 A RU93030389/14 A RU 93030389/14A RU 93030389 A RU93030389 A RU 93030389A RU 93030389 A RU93030389 A RU 93030389A
- Authority
- RU
- Russia
- Prior art keywords
- function
- mesh eye
- means restoring
- restoring
- eye
- Prior art date
Links
- 239000003814 drug Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 230000001771 impaired Effects 0.000 claims 1
- 230000001575 pathological Effects 0.000 claims 1
- 230000004243 retinal function Effects 0.000 claims 1
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93030389A RU2073518C1 (en) | 1993-06-17 | 1993-06-17 | Agent recovering retina eye function |
PCT/IB1994/000192 WO1995000156A1 (en) | 1993-06-17 | 1994-06-17 | Compositions and methods for treatment and prevention of retinal dysfunctions |
AU69795/94A AU6979594A (en) | 1993-06-17 | 1994-06-17 | Compositions and methods for treatment and prevention of retinal dysfunctions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93030389A RU2073518C1 (en) | 1993-06-17 | 1993-06-17 | Agent recovering retina eye function |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93030389A true RU93030389A (en) | 1995-06-27 |
RU2073518C1 RU2073518C1 (en) | 1997-02-20 |
Family
ID=20142934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93030389A RU2073518C1 (en) | 1993-06-17 | 1993-06-17 | Agent recovering retina eye function |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6979594A (en) |
RU (1) | RU2073518C1 (en) |
WO (1) | WO1995000156A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
CA3148917A1 (en) * | 2006-03-08 | 2007-09-13 | Archemix Llc | Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders |
RU2301072C1 (en) * | 2006-06-22 | 2007-06-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Agent for normalizing of blood-vessel function and method for production thereof |
RU2558976C2 (en) * | 2013-09-19 | 2015-08-10 | Венера Айратовна Шаимова | Method of predicting development of vitreoretinal traction in case of peripheral retinal degeneration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2117057C3 (en) * | 1971-04-07 | 1980-07-31 | Biofarm Fabrica De Medicamente, Bukarest (Rumaenien) | Process for the manufacture of a medicament for the treatment of eye diseases |
IT1219839B (en) * | 1988-02-08 | 1990-05-24 | Fidia Farmaceutici | PURIFICATION, CHARACTERIZATION AND APPLICATION OF A NEURONOTROPHIC FACTOR DERIVED FROM NAMMIFEROUS BRAIN |
IT1219874B (en) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | USE OF THE HUMAN NERVE GROWTH FACTOR AND ITS PHARMACEUTICAL COMPOSITIONS |
US5166317A (en) * | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
-
1993
- 1993-06-17 RU RU93030389A patent/RU2073518C1/en active
-
1994
- 1994-06-17 AU AU69795/94A patent/AU6979594A/en not_active Withdrawn
- 1994-06-17 WO PCT/IB1994/000192 patent/WO1995000156A1/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE241365T1 (en) | PREPARATIONS CONTAINING SACCHARIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES | |
KR960700742A (en) | ATOPIC DISEASE REMEDY | |
ATE293417T1 (en) | SCLEROTIC PROSTHESIS FOR THE TREATMENT OF PRESBIOUS SIGHT AND OTHER EYE DISEASES | |
CA2041260A1 (en) | Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents | |
EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
PT668763E (en) | USE OF FENSERIN FOR THE PREPARATION OF MEDICINES TO TREAT DISEASES OF KNOWLEDGE | |
RU94002133A (en) | 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION | |
EP1538163A3 (en) | Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease | |
RU93030389A (en) | MEANS RESTORING THE FUNCTION OF THE MESH EYE | |
DE69618560D1 (en) | MEDICINE AGAINST OPHTHALMIC DISEASES | |
DE69007065D1 (en) | Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases. | |
FI942400A0 (en) | Drug against nerve diseases | |
IT9020968A0 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC DISEASES | |
CA2167257A1 (en) | Use of Sertraline to Treat Cancer Patients | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
BR9406865A (en) | Use of a pharmaceutically acceptable salt of ropivacaine in the manufacture of a pharmaceutical process for the treatment of a person in need of pain relief and pharmaceutical preparation | |
BR9809457A (en) | Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy. | |
DE69739190D1 (en) | MEDICAMENT FOR THE TREATMENT OF OCULAR CRUSH DISEASES | |
FR2644060B1 (en) | MEDICINE, ESPECIALLY FOR THE TREATMENT OF CUTANEOUS, EYE AND GENITAL HERPES VIRUS DISEASES | |
CA2135752A1 (en) | Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease | |
GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
HUP0004647A2 (en) | Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye | |
KR960003718A (en) | Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases | |
DE69421705T2 (en) | Use of Efaroxan and its derivatives for the manufacture of a medicament for the treatment of neurogenerative diseases | |
FI953725A0 (en) | Use of ornithine aminotransferase inhibitors in the manufacture of a medicament for the treatment of Alzheimer's disease |